Fingerprint
Dive into the research topics of 'FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: An international consortium study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: An international consortium study
Ravit Geva, Loredana Vecchione, Konstantinos T. Kalogeras, Benny Vittrup Jensen, Heinz Josef Lenz, Takayuki Yoshino, David Paez, Clara Montagut, John Souglakos, Federico Cappuzzo, Andrés Cervantes, Milo Frattini, George Fountzilas, Julia S. Johansen, Estrid Vilma Høgdall, Wu Zhang, Dongyun Yang, Kentaro Yamazaki, Tomohiro Nishina, Demetris Papamichael
*Corresponding author for this work
- Tel Aviv Sourasky Medical Center
- KU Leuven
- Hellenic Cooperative Oncology Group
- University of Copenhagen
- University of Southern California
- National Cancer Center Japan
- Hospital de La Santa Creu I Sant Pau
- Hospital del Mar
- Heraklion University Hospital
- USL Nordovest Toscana
- University of Valencia
- Instituto Cantonale di Patologia
- Shizuoka Cancer Center
- National Hospital Organization Shikoku Cancer Center
- Bank of Cyprus Oncology Centre
- Universita Campus Bio-Medico di Roma
- University Hospital Vall d'Hebron
- University of Pisa
- University of Southern Denmark
- University of Campania Luigi Vanvitelli
- Université catholique de Louvain
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations